HCG Manavata Cancer Centre Observes World Leukemia Day With A Call For Awareness & Early Diagnosis

▴ Dr_Priyatesh_Dwivedi__Hemato-oncology_and_BMT_Specialist__HCG_Manavata_Cancer__Centre
On the occasion of World Leukemia Day - 4th September, HCG Manavata Cancer Centre (HCGMCC) emphasized the urgent need for awareness, early detection and advanced treatment of leukemia, a complex blood cancer that affects thousands of people across India every year.

Hello! If you're looking for high-quality genericmedications, fast delivery and excellent customer service, ourstore is the right choice for you. With over 20 years of onlineexperience, we guarantee safe, effective products that are alwaysin stock. Delivery within 48 hours, free shipping from $200, and 100% money-back guarantee if your order doesn't arrive on time.

👉 Order now at BestCheapPills and discover exclusive discounts for registeredcustomers!

Nashik, Sept 04: On the occasion of World Leukemia Day - 4th September, HCG Manavata Cancer Centre (HCGMCC) emphasized the urgent need for awareness, early detection and advanced treatment of leukemia, a complex blood cancer that affects thousands of people across India every year. Leukemia originates in the blood and bone marrow, primarily affecting white blood cells. These abnormal cells multiply uncontrollably, weakening the immune system and crowding out healthy blood cells. While leukemia can occur at any age, the risk increases with age. Children, however, are also vulnerable, with Acute Lymphocytic Leukemia (ALL) being the most common type. Other types including Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL) and Chronic Myeloid Leukemia (CML) are more common in adults.

“The challenge with leukemia is that its symptoms which include loss of appetite, persistent fatigue, bone pain, recurrent infections, unexplained weight loss and, easy bruising and bleeding are often overlooked or mistaken for other conditions. If such signs persist, immediate medical consultation is critical. With innovations like CAR-T Cell Therapy and targeted therapies, we’re not just treating cancer, we’re curing it. At HCGMCC, we’ve made these therapies accessible so patients in Nashik don’t have to travel to metros for world-class care,” says Dr Priyatesh Dwivedi, Hemato-oncology and BMT Specialist, HCGMCC.

Accurate diagnosis is key. Common tests include complete blood counts, peripheral blood smears, bone marrow biopsies, imaging scans, flow cytometry and molecular tests. At HCGMCC, specialists combine these with advanced technologies to ensure precise staging and treatment planning.

“Thanks to breakthroughs in targeted and immune therapies and wider adoption of stem cell transplants, many patients are now able to lead longer and healthier lives after treatment. Our mission is to bring these global advancements locally, ensuring that patients in tier 2 and tier 3 cities like Nashik have access to world-class care,” adds Dr Dwivedi.

Treatment options for leukemia have significantly advanced and include Chemotherapy, Radiation therapy, Targeted therapy, Immunotherapy, Stem cell transplants and CAR-T Cell Therapy.

“This World Leukemia Day calls for greater public awareness and proactive screening. By bridging global medical innovations with local access, we continue to redefine cancer care in India,” concludes Dr Dwivedi.

Leukemia accounts for a significant proportion of blood cancers worldwide. The common risk factors include family history, smoking and tobacco use, genetic disorders, exposure to harmful chemicals and radiation. Early detection and timely treatment significantly improve survival rates.

About HCG Manavata Cancer Centre (HCGMCC): -

Established in 2007 by Dr Raj Nagarkar, HCGMCC – Nashik is Central India's first NABH-accredited facility. With over 54 consultant oncologists, 900 staff members and a 275-bed capacity, HCGMCC is a leading institution, offering holistic cancer treatment. Specializing in surgical, radiation and medical oncology, the centre has conducted 95,000 surgeries, including 1,600 plus robotic-assisted procedures. Patient-centric and multidisciplinary, HCGMCC recommends treatments to individual needs. Beyond clinical excellence, the centre’s financial aid programs underscore its commitment to accessibility and community well-being, redefining cancer care in the pursuit of a cancer-free future.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026